Morus alba L.
Species
KNApSAcK Entry
| Organism name | Morus alba L. |
|---|---|
| Genus | Morus |
| Family | Moraceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Morus alba |
|---|---|
| Linked NCBI taxonomy ID | 3498 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Moraceae |
|---|---|
| ID | 3487 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | rosids |
|---|---|
| ID | 71275 |
Natural Activity
List (29)
| Species | Activity |
|---|---|
| Morus alba L. | Analgesic |
| Morus alba L. | Antiaging |
| Morus alba L. | Antibacterial |
| Morus alba L. | Antiinflammatory |
| Morus alba L. | Antileukemic |
| Morus alba L. | Antioxidant |
| Morus alba L. | Antipyretic |
| Morus alba L. | Antiradicular |
| Morus alba L. | Antispasmodic |
| Morus alba L. | Antitumor |
| Morus alba L. | Astringent |
| Morus alba L. | Diaphoretic |
| Morus alba L. | Diuretic |
| Morus alba L. | Emollient |
| Morus alba L. | Expectorant |
| Morus alba L. | Fungicide |
| Morus alba L. | Glucosidase Inhibitor |
| Morus alba L. | Hypoglycemic |
| Morus alba L. | Hypotensive |
| Morus alba L. | Immunomodulator |
| Morus alba L. | Lactagogue |
| Morus alba L. | Laxative |
| Morus alba L. | Lymphocytogenic |
| Morus alba L. | Nematicide |
| Morus alba L. | Pectoral |
| Morus alba L. | Propecic |
| Morus alba L. | Sedative |
| Morus alba L. | Tranquilizer |
| Morus alba L. | Vermifuge |
Metabolite list (5)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00029329
|
Roseoside
/ Roseoside A / Roseoside II / (6S,9R)-Roseoside / Vomifoliol beta-D-glucopyranoside |
|
||||||
|
C00005138
|
Astragalin
/ Kaempferol 3-glucoside / Kaempferol 3-O-beta-D-glucoside / Kaempferol 3-O-beta-D-glucopyranoside |
CHEMBL233930
CHEMBL453290 CHEMBL1572115 |
C001579
|
10 / 6 / 7 | 0 / 1 | No. 2 | No. 15 |
|
|
C00029812
|
Benzyl beta-D-glucopyranoside
/ (-)-Benzyl-O-beta-D-glucopyranoside |
CHEMBL1170453
CHEMBL2336738 |
C410942
|
No. 45 | No. 72 |
|
||
|
C00002500
|
Scopolin
|
CHEMBL225024
|
C417572
|
7 / 3 / 4 | No. 491 | No. 25 |
|
|
|
C00032165
|
Skimmin
/ (-)-Skimmin |
CHEMBL526377
|
No. 491 | No. 25 |
|
Human Protein / Gene in interactions
17 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q99700 | Ataxin-2 | Unclassified protein | C00005138 | 1 / 1 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00002500 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005138 | 0 / 0 |
| Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002500 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00002500 | 1 / 2 |
| P07237 | Protein disulfide-isomerase | Enzyme | C00005138 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00002500 | 1 / 2 |
| P15121 | Aldose reductase | Enzyme | C00005138 | 0 / 0 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00002500 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00005138 | 1 / 1 |
| P14679 | Tyrosinase | Oxidoreductase | C00005138 | 4 / 2 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002500 | 0 / 1 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005138 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00002500 | 1 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00005138 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005138 | 0 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00005138 | 0 / 3 |
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (9)
| OMIM | preferred title | UniProt |
|---|---|---|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (11)
| KEGG | name | UniProt |
|---|---|---|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|